Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Yuichiro Tsurugai"'
Autor:
Takahisa Eriguchi, Atsuya Takeda, Takafumi Nemoto, Yuichiro Tsurugai, Naoko Sanuki, Yudai Tateishi, Yuichi Kibe, Takeshi Akiba, Mari Inoue, Kengo Nagashima, Nobuyuki Horita
Publikováno v:
Cancers, Vol 14, Iss 15, p 3815 (2022)
Variations in dose prescription methods in stereotactic body radiotherapy (SBRT) for early stage non-small-cell lung cancer (ES-NSCLC) make it difficult to properly compare the outcomes of published studies. We conducted a comprehensive search of the
Externí odkaz:
https://doaj.org/article/d25d09907c354dc9b9d3531ba32b9335
Autor:
Yuto Kimura, Atsuya Takeda, Takahisa Eriguchi, Yohei Oku, Yuichi Kibe, Yuichiro Tsurugai, Naoki Nakamura
Publikováno v:
Acta Oncologica. 61:104-110
Background The feasibility of marker-less stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) has not yet been established, and, thus, was examined in the present study. Material and methods We retrospectively investigated patien
Autor:
Nobuyuki Horita, Takahisa Eriguchi, Takeshi Kaneko, Naoko Sanuki, Yudai Tateishi, Atsuya Takeda, Yuichi Kibe, Yuichiro Tsurugai
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:143-151
Purpose We investigated whether delivery of a high biologically effective dose (BED) to primary tumors affects systemic outcomes of cancer-specific death (CSD) and overall survival (OS) rates after stereotactic body radiation therapy (SBRT) in patien
Autor:
Naoko Sanuki, Atsuya Takeda, Takahisa Eriguchi, Yuichiro Tsurugai, Yudai Tateishi, Yuichi Kibe, Takeshi Akiba, Tsuyoshi Fukuzawa, Nobuyuki Horita
Publikováno v:
Radiotherapy and Oncology. 183:109664
Autor:
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Noriko Kishi, Takahisa Eriguchi, Etsuo Kunieda, Ryusei Kimura, Naoko Sanuki, Yuichiro Tsurugai, Masamichi Yagi, Yousuke Aoki, Yohei Oku, Yuto Kimura, Changhee Han, Naoyuki Shigematsu
Publikováno v:
JCO clinical cancer informatics. 6
PURPOSE Clear evidence indicating whether surgery or stereotactic body radiation therapy (SBRT) is best for non–small-cell lung cancer (NSCLC) is lacking. SBRT has many advantages. We used artificial neural networks (NNs) to predict treatment outco
Autor:
Naoko Sanuki, Takahisa Eriguchi, Norio Katoh, Atsuya Takeda, Masaki Kokubo, Tomoki Kimura, Yohei Oku, Yuichiro Tsurugai, Satoshi Ishikura, Shinichi Shimizu, Shuichi Ozawa, Keisuke Ariyoshi, Takuhiro Yamaguchi, T. Imagumbai
Publikováno v:
Hepatology Research. 51:461-471
AIM To prospectively evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) for patients with previously untreated solitary primary hepatocellular carcinoma (HCC). METHODS The main eligibility criteria included the following: (1) p
Publikováno v:
Hepatology Research. 51:294-302
Aim Decisions regarding therapeutic plans for inoperable patients with hepatocellular carcinoma (HCC) adjacent to the gastrointestinal (GI) tract are challenging because radiofrequency ablation has the potential risk of thermal injury. Moreover, the
Autor:
Yuichiro Tsurugai, Tomoki Kimura, Yohei Oku, Atsuya Takeda, Hideharu Miura, Kazunari Hioki, Yoshiko Doi, Reo Kawano, Yasushi Nagata
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:1265-1275
Purpose Through this multi-institutional study, we aimed to retrospectively evaluate the safety and efficacy of repeated stereotactic body radiation therapy (SBRT) for intrahepatic recurrent hepatocellular carcinoma (HCC). Methods and Materials Betwe
Publikováno v:
Japanese journal of radiology. 40(10)
In the treatment of colorectal cancer patients with distant metastases, the development of new anticancer agents has considerably prolonged progression-free survival. Such survival benefits attributed to chemotherapy have increased the relative signi
Publikováno v:
Acta Oncologica. 59:888-894
Background: To clarify local control by salvage stereotactic body radiotherapy (SBRT) for recurrent/residual hepatocellular carcinoma (HCC) compared with initial definitive SBRT for local treatment...